Interventional Cardiology and Peripheral Vascular Devices Market | Key Player include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical, Inc., Medtronic plc, St. Jude Medical,

Interventional Cardiology and Peripheral Vascular Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $25,349 million by 2022, registering a CAGR of 9.7% during the period 2016-2022. Angioplasty stent systems are estimated to generate the highest revenue among all segments throughout the forecast period, owing to technological advancements and development of bioabsorbable stents. North America held the leading position in the global market in 2015, and is expected to maintain its lead in the future. This is attributed to the increase in incidence of heart failures, changes in lifestyle, and high adoption of interventional cardiology and peripheral vascular devices in the region.

Download Now! Sample PDF Brochure @ https://www.alliedmarketresearch.com/request-sample/1072

Growth in geriatric population,increase in prevalence of chronic diseases, changes in lifestyle of the people, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. However, stringent approval process for interventional cardiology and peripheral vascular devices is a major factor that hampers the market growth.

Plaque modification devices are projected to be thefastest growing segment, with a CAGR of 13.7% from 2016 to 2022, as these devices provide an efficient alternative when ballooning of arteries fail. In addition, plaque removal is also important before a stent implant as this helps in prevention of restenosis in the arteries. Apart from this, increase in incidences of plaque buildup in coronary as well as peripheral arteries and minimally invasive nature of the procedure will also drive the market.

Bioabsorbable stents system is expected to register a very high CAGR of 46.0% during the forecast period as this system is fully absorbed into the body and eliminates chances of restenosis. In addition, bioabsorbable stents improve endothelial function, avoid the loss of blood, and restore normal vasomotion. This is not possible when bare metal stents are used. Therefore, bioabsorbable stents would grow with a very high growth rate.

Key findings of the Interventional Cardiology and Peripheral Vascular Devices Market:
• On the basis of product type, angioplasty stents segment accounted for more than half of the total market in 2015.
• Plaque modification devices are expected to grow at high rate (with a CAGR of 13.7%) as use of these devices before stent implant decreases the chances of restenosis.
• North America accounted for more than one-third of the total market in 2015, and it is projected to lead the overall market in the forecast period.
• Asia-Pacific is expected to be the fastest growing region (with a CAGR of 10.4%) throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of cardiac disorders in this region.

Key players have adopted product development as their key strategy to cater to the changing needs of the industry. Major players operating in this market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical, Inc., Medtronic plc, St. Jude Medical, Inc., Terumo Corporation, and The Spectranetics Corporation. As of 2015, Medtronic dominated the overall renal denervation market, followed by Abbott Laboratories and Boston Scientific Corporation.

TABLE OF CONTENT:

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Key players
1.5 Research methodology

1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.2.2.1 Competitive intelligence of companies and their strategies

3.3 Market share analysis, 2015
3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.4.1.2 Technological advancements
3.4.1.3 Improving healthcare infrastructure in developing countries
3.4.1.4 Development of minimally invasive procedures
3.4.1.5 Increasing patient awareness

3.4.2 Restraints

3.4.2.1 High treatment cost
3.4.2.2 Stringent approval process for interventional cardiology and peripheral vascular devices

3.4.3 Opportunities

3.4.3.1 Huge market opportunities in developing countries
3.4.3.2 Development of Bioabsorbable stents

3.5 Clinical Trials

Chapter: 4 WORLD INTERVENTIONAL CARDIOLGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Angioplasty Balloons

4.2.1 Old/Normal balloons
4.2.2 Cutting and scoring balloons
4.2.3 Drug eluting balloons
4.2.4 Key market trends
4.2.5 Key growth factors and opportunities
4.2.6 Market size and forecast

4.3 Angioplasty Stents

4.3.1 Coronary stents

4.3.1.1 Bare-metal stents
4.3.1.2 Drug-eluting stents (DES)
4.3.1.3 Bioabsorbable stents

4.3.2 Peripheral stents
4.3.3 Key market trends
4.3.4 Key growth factors and opportunities
4.3.5 Market size and forecast

4.4 Angioplasty Catheters

4.4.1 Angiography Catheters
4.4.2 Guiding Catheters
4.4.3 Key market trends
4.4.4 Key growth factors and opportunities
4.4.5 Market size and forecast

4.5 Endovascular Aneurysm Repair Stent Grafts

4.5.1 Abdominal aortic aneurysm
4.5.2 Thoracic aortic aneurysm
4.5.3 Key market trends
4.5.4 Key growth factors and opportunities
4.5.5 Market size and forecast

4.6 Inferior Vena Cava (IVC) Filters

4.6.1 Permanent filters
4.6.2 Retrievable filters
4.6.3 Key market trends
4.6.4 Key growth factors and opportunities
4.6.5 Market size and forecast

4.7 Plaque Modification Devices

4.7.1 Thrombectomy devices
4.7.2 Atherectomy devices
4.7.3 Key market trends
4.7.4 Key growth factors and opportunities
4.7.5 Market size and forecast

4.8 Hemodynamic Flow Alteration Devices

4.8.1 Embolic protection devices
4.8.2 Chronic total occlusion devices
4.8.3 Key market trends
4.8.4 Key growth factors and opportunities
4.8.5 Market size and forecast

4.9 Accessories

4.9.1 Vascular closure devices
4.9.2 Introducer sheaths
4.9.3 Guidewires
4.9.4 Balloon inflation devices
4.9.5 Key market trends
4.9.6 Key growth factors and opportunities
4.9.7 Market size and forecast

Chapter: 5 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S. market size and forecast
5.2.5 Canada market size and forecast
5.2.6 Mexico market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany market size and forecast
5.3.5 France market size and forecast
5.3.6 U.K. market size and forecast
5.3.7 Italy market size and forecast
5.3.8 Spain market size and forecast
5.3.9 Rest of Europe market size and forecast

5.4 Asia-Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Japan market size and forecast
5.4.5 China market size and forecast
5.4.6 India market size and forecast
5.4.7 Malaysia market size and forecast
5.4.8 Australia market size and forecast
5.4.9 Rest of Asia-Pacific market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Brazil market size and forecast
5.5.5 South Africa market size and forecast
5.5.6 Egypt market size and forecast
5.5.7 Rest of LAMEA market size and forecast

Chapter: 6 COMPANY PROFILES

6.1 Abbott Laboratories

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 B. Braun Melsungen AG

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Operating Business Segments
6.2.4 Business Performance
6.2.5 Key Strategic Moves & Developments

6.3 Boston Scientific Corporation

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves & Developments

6.4 C. R. Bard, Inc.

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business Performance
6.4.5 Key Strategic Moves & Developments

6.5 Cardinal Health, Inc.

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves & Developments

6.6 Cook Medical, Inc.

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Key Strategic Moves & Developments

6.7 Medtronic plc

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 St. Jude Medical, Inc.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves & Developments

6.9 Terumo Corporation

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 The Spectranetics Corporation

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Business Performance
6.10.5 Key Strategic Moves & Developments

Check offers and discount on this report @ https://www.alliedmarketresearch.com/get-discount/1072

About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.